Articles:

AP Ford, NF Arredondo, DR Jr Blue, DW Bonhaus, J Jasper, MS Kava, J Lesnick, JR Pfister, IA Shieh, RL Vimont, TJ Williams, JE McNeal, TA Stamey, and DE Clarke

RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification
Mol Pharmacol 1996 49: 209-215. [Abstract] [PDF]  

K Befort, L Tabbara, S Bausch, C Chavkin, C Evans, and B Kieffer

The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site
Mol Pharmacol 1996 49: 216-223. [Abstract] [PDF]  

DR Gehlert, LS Beavers, D Johnson, SL Gackenheimer, DA Schober, and RA Gadski

Expression cloning of a human brain neuropeptide Y Y2 receptor
Mol Pharmacol 1996 49: 224-228. [Abstract] [PDF]  

MD Hollenberg, M Saifeddine, and B al-Ani

Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides
Mol Pharmacol 1996 49: 229-233. [Abstract] [PDF]  

JS Leeder, A Gaedigk, X Lu, and VA Cook

Epitope mapping studies with human anti-cytochrome P450 3A antibodies
Mol Pharmacol 1996 49: 234-243. [Abstract] [PDF]  

JM Rusnak, TP Calmels, DG Hoyt, Y Kondo, JC Yalowich, and JS Lazo

Genesis of discrete higher order DNA fragments in apoptotic human prostatic carcinoma cells
Mol Pharmacol 1996 49: 244-252. [Abstract] [PDF]  

KL Hadingham, EM Garrett, KA Wafford, C Bain, RP Heavens, DJ Sirinathsinghji, and PJ Whiting

Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors
Mol Pharmacol 1996 49: 253-259. [Abstract] [PDF]  

SP Carpenter, JM Lasker, and JL Raucy

Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes
Mol Pharmacol 1996 49: 260-268. [Abstract] [PDF]  

Z Wang and BK Sinha

Interleukin-1 alpha-induced modulation of topoisomerase I activity and DNA damage: implications in the mechanisms of synergy with camptothecins in vitro and in vivo
Mol Pharmacol 1996 49: 269-275. [Abstract] [PDF]  

SJ Webb, GH Xiao, TE Geoghegan, and RA Prough

Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone
Mol Pharmacol 1996 49: 276-287. [Abstract] [PDF]  

X Zhang and CD Smith

Microtubule effects of welwistatin, a cyanobacterial indolinone that circumvents multiple drug resistance
Mol Pharmacol 1996 49: 288-294. [Abstract] [PDF]  

PF Wick, RE Westenbroek, and RW Holz

Effects of expression of a mouse brain L-type calcium channel alpha 1 subunit on secretion from bovine adrenal chromaffin cells
Mol Pharmacol 1996 49: 295-302. [Abstract] [PDF]  

JL Venero, F Hefti, and B Knusel

Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: comparison between intraparenchymal and intraventricular administration
Mol Pharmacol 1996 49: 303-310. [Abstract] [PDF]  

EG Schuetz, WT Beck, and JD Schuetz

Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells
Mol Pharmacol 1996 49: 311-318. [Abstract] [PDF]  

JH Prehn, VP Bindokas, J Jordan, MF Galindo, GD Ghadge, RP Roos, LH Boise, CB Thompson, S Krajewski, JC Reed, and RJ Miller

Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons
Mol Pharmacol 1996 49: 319-328. [Abstract] [PDF]  

K Sterling and E Bresnick

Oct-1 transcription factor is a negative regulator of rat CYP1A1 expression via an octamer sequence in its negative regulatory element
Mol Pharmacol 1996 49: 329-337. [Abstract] [PDF]  

D Sulzer, C St Remy, and S Rayport

Reserpine inhibits amphetamine action in ventral midbrain culture
Mol Pharmacol 1996 49: 338-342. [Abstract] [PDF]  

B Rene, P Fosse, T Khelifa, A Jacquemin-Sablon, and C Bailly

The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity
Mol Pharmacol 1996 49: 343-350. [Abstract] [PDF]  

JA Koenig and JM Edwardson

Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type
Mol Pharmacol 1996 49: 351-359. [Abstract] [PDF]  

HY Kim, D Thomas, and MR Hanley

Stimulation of Ca(2+)-dependent membrane currents in Xenopus oocytes by microinjection of pyrimidine nucleotide-glucose conjugates
Mol Pharmacol 1996 49: 360-364. [Abstract] [PDF]  

E Hermans, JN Octave, and JM Maloteaux

Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization
Mol Pharmacol 1996 49: 365-372. [Abstract] [PDF]  

I Yamaguchi, SF Walk, PA Jose, and RA Felder

Dopamine D2L receptors stimulate Na+/K(+)-ATPase activity in murine LTK- cells
Mol Pharmacol 1996 49: 373-378. [Abstract] [PDF]  

KB Walsh, SP Wilson, KJ Long, and SC Lemon

Stimulatory regulation of the large-conductance, calcium-activated potassium channel by G proteins in bovine adrenal chromaffin cells
Mol Pharmacol 1996 49: 379-386. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.